m+Medelevator.RU
← Поиск публикаций
Cell reports · 2016

Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation.

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Gingras Marie-Claude, Covington Kyle R, Chang David K, Donehower Lawrence A, Gill Anthony J, Ittmann Michael M, Creighton Chad J, Johns Amber L, Shinbrot Eve, Dewal Ninad, Fisher William E, Australian Pancreatic Cancer Genome Initiative, Pilarsky Christian, Grützmann Robert, Overman Michael J, Jamieson Nigel B, Van Buren George, Drummond Jennifer, Walker Kimberly, Hampton Oliver A, Xi Liu, Muzny Donna M, Doddapaneni Harsha, Lee Sandra L, Bellair Michelle, Hu Jianhong, Han Yi, Dinh Huyen H, Dahdouli Mike, Samra Jaswinder S, Bailey Peter, Waddell Nicola, Pearson John V, Harliwong Ivon, Wang Huamin, Aust Daniela, Oien Karin A, Hruban Ralph H, Hodges Sally E, McElhany Amy, Saengboonmee Charupong, Duthie Fraser R, Grimmond Sean M, Biankin Andrew V, Wheeler David A, Gibbs Richard A

Аннотация

The ampulla of Vater is a complex cellular environment from which adenocarcinomas arise to form a group of histopathologically heterogenous tumors. To evaluate the molecular features of these tumors, 98 ampullary adenocarcinomas were evaluated and compared to 44 distal bile duct and 18 duodenal adenocarcinomas. Genomic analyses revealed mutations in the WNT signaling pathway among half of the patients and in all three adenocarcinomas irrespective of their origin and histological morphology. These tumors were characterized by a high frequency of inactivating mutations of ELF3, a high rate of microsatellite instability, and common focal deletions and amplifications, suggesting common attributes in the molecular pathogenesis are at play in these tumors. The high frequency of WNT pathway activating mutation, coupled with small-molecule inhibitors of β-catenin in clinical trials, suggests future treatment decisions for these patients may be guided by genomic analysis.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты